{
"@context": "https://schema.org",
"@type": "Article",
"headline": "New Opportunities, New Challenges: FDA Elaborates on use of Digital Health in Drug and Biological Product Development",
"url": "https://www.lexblog.com/2023/04/21/new-opportunities-new-challenges-fda-elaborates-on-use-of-digital-health-in-drug-and-biological-product-development/",
"identifier": {
"@type": "PropertyValue",
"name": "LexBlog Library record",
"value": "LEX-WK-BXFYPS54",
"url": "https://www.lexblog.com/lib/BXFYPS54/"
},
"datePublished": "2023-04-21T10:40:21-04:00",
"dateModified": "2023-04-21T11:06:16-04:00",
"author": {
"@type": "Person",
"name": "Sarah Thompson Schick, Rebecca Jones McKnight, Vicki Tankle, Roswill Mejia"
},
"sourceOrganization": {
"@type": "Organization",
"name": "Reed Smith LLP"
},
"organizationScope": "at-publication",
"isPartOf": "Health Industry Washington Watch",
"about": "Health Care and Life Sciences",
"sourceUrl": "https://www.healthindustrywashingtonwatch.com/?p=26050",
"sourceStability": "may-move"
}